A Multicentered, Double - Blind, Randomized, and Placebo - Controlled Clinical Trial With Inactivated Enterovirus Type 71 (EV71) Vaccines.

Trial Profile

A Multicentered, Double - Blind, Randomized, and Placebo - Controlled Clinical Trial With Inactivated Enterovirus Type 71 (EV71) Vaccines.

Completed
Phase of Trial: Phase III

Latest Information Update: 14 May 2015

At a glance

  • Drugs Enterovirus A vaccine (Primary)
  • Indications Coxsackievirus infections; Enterovirus A infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 14 May 2015 Data from this trial supported the filing of a new drug application with the China Food & Drug Administration, and batch testing is being conducted, according to a Sinovac Biotech media release.
    • 27 Feb 2014 Results published in the New England Journal of Medicine.
    • 26 Feb 2014 Results have been published in The New England Journal of Medicine according to a Sinovac media release. Results were also summarised in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top